Product Information
CLIND PH-BENZOYL PERO 1.2-2.5% is a generic product labeled by Encube Ethicals, Inc., priced at $0.8191 per GM under NDC 21922007440. Its NADAC has been published 80 times since Mar 26, 2025.
FDA first approved this application on Aug 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 10 mg/g; mg/g
Manufacturer
Encube Ethicals, Inc.NDC
21922007440
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA207194FDA Approved
8/19/2019
TE Code
AB
On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has been published 80 times since Mar 26, 2025, and over the history we have for it it has declined 37.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8191 per GM |
|---|---|
| All-time high | $1.3083 (Apr 16, 2025) |
| All-time low | $0.6671 (Jul 22, 2026) |
| 52-week high | $0.9869 |
| 52-week low | $0.6671 |
| Median price | $0.8163 |
| Average price | $0.9345 |
| Largest weekly change | -14.9% (Sep 17, 2025) |
| Weeks tracked | 80 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Encube Ethicals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLIND PH-BENZOYL PERO 1.2-2.5%?
The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PERO 1.2-2.5%, manufactured by Encube Ethicals, Inc., is $0.8191 per GM (NDC 21922007440), effective Sep 30, 2026.
How has the price of CLIND PH-BENZOYL PERO 1.2-2.5% changed over time?
Over the history we have for it, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has declined 37.4%. It has been tracked across 80 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PERO 1.2-2.5%?
Since Mar 26, 2025, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has ranged from a low of $0.6671 (Jul 22, 2026) to a high of $1.3083 (Apr 16, 2025), with a median of $0.8163 per GM.
Are there cheaper alternatives to CLIND PH-BENZOYL PERO 1.2-2.5%?
No other NADAC-published product currently shares the active ingredient and strength of CLIND PH-BENZOYL PERO 1.2-2.5% in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLIND PH-BENZOYL PERO 1.2-2.5%?
CLIND PH-BENZOYL PERO 1.2-2.5% (NDC 21922007440) is labeled by Encube Ethicals, Inc., and CMS classifies it as a generic product.